Investor Relations

Webcasts and Presentations

Webcasts

Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2024 Financial Results

Jan. 28, 2025

Presentations

Neurocrine Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan. 13, 2025

Download

Go To Webcasts & Presentations

Latest News Releases

01/30/25

Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2024 Financial Results

01/28/25

Neurocrine Biosciences Announces Initiation of Phase 3 Registrational Program for Osavampator as an Adjunctive Therapy for the Treatment of Major Depressive Disorder in Adults

View All News Releases

Q3 Earnings

Press Release Webcast Presentation

Latest Filings

Filing Date	Form	Description	Filing Group	View
02/03/25	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	Other	View the html document View the rtf document View the pdf document View the xls document
01/31/25	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	Other	View the html document View the rtf document View the pdf document
01/31/25	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	Other	View the html document View the rtf document View the pdf document